Evidence map›Paper›PMID 30737390›Full record

ArticleNature communications2019

Chaperone activation and client binding of a 2-cysteine peroxiredoxin.

Filipa Teixeira, Eric Tse, Helena Castro, Karl A T Makepeace, Ben A Meinen, Christoph H Borchers, Leslie B Poole, James C Bardwell, Ana M Tomás, Daniel R Southworth and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Chimerization expands peroxiredoxin scope.Nature chemical biology · 2026
    Article
  4. HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Frontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Cross-talk between redox signalling and protein aggregation.Biochemical Society transactions · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Filipa TeixeiraDepartment of Molecular, Cellular and Developmental, University of Michigan, Ann Arbor, 48109-1085, MI, USA.
Eric TseDepartment of Biochemistry and Biophysics, Institute for Neurodegenerative Diseases, University of California, San Francisco, 94158, CA, USA.ORCID http://orcid.org/0000-0002-2082-9006
Helena Castroi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, 4200-135, Portugal.
Karl A T MakepeaceDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, V8P 5C2, BC, Canada.
Ben A MeinenDepartment of Molecular, Cellular and Developmental, University of Michigan, Ann Arbor, 48109-1085, MI, USA.
Christoph H BorchersDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, V8P 5C2, BC, Canada.
Leslie B PooleDepartment of Biochemistry, Wake Forest School of Medicine, Winston-Salem, 27157, NC, USA.
James C BardwellDepartment of Molecular, Cellular and Developmental, University of Michigan, Ann Arbor, 48109-1085, MI, USA.
Ana M Tomási3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, 4200-135, Portugal.
Daniel R SouthworthDepartment of Biochemistry and Biophysics, Institute for Neurodegenerative Diseases, University of California, San Francisco, 94158, CA, USA. daniel.southworth@ucsf.edu.
Ursula JakobDepartment of Molecular, Cellular and Developmental, University of Michigan, Ann Arbor, 48109-1085, MI, USA. ujakob@umich.edu.

Funding

Role of Molecular Chaperones in Stress Response and DiseaseR35GM122506 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ursula H. Jakob · 2017 to 2026
$6.8M
Defining the conformational cycle of nitric oxide synthasesR01GM110001 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SOUTHWORTH, DANIEL RYLAND · 2015 to 2019
$1.5M
Mechanisms and Regulation of PeroxiredoxinsR01GM119227 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI POOLE, LESLIE B · 2016 to 2019
$1.4M
NIGMS NIH HHS R01 GM110001NIGMS NIH HHS R01 GM119227NIGMS NIH HHS R35 GM122506
6 · The paper itself

Abstract

Many 2-Cys-peroxiredoxins (2-Cys-Prxs) are dual-function proteins, either acting as peroxidases under non-stress conditions or as chaperones during stress. The mechanism by which 2-Cys-Prxs switch functions remains to be defined. Our work focuses on Leishmania infantum mitochondrial 2-Cys-Prx, whose reduced, decameric subpopulation adopts chaperone function during heat shock, an activity that facilitates the transition from insects to warm-blooded host environments. Here, we have solved the cryo-EM structure of mTXNPx in complex with a thermally unfolded client protein, and revealed that the flexible N-termini of mTXNPx form a well-resolved central belt that contacts and encapsulates the unstructured client protein in the center of the decamer ring. In vivo and in vitro cross-linking studies provide further support for these interactions, and demonstrate that mTXNPx decamers undergo temperature-dependent structural rearrangements specifically at the dimer-dimer interfaces. These structural changes appear crucial for exposing chaperone-client binding sites that are buried in the peroxidase-active protein.

Indexed as

Cryoelectron MicroscopyCysteineLeishmania infantumMolecular ChaperonesPeroxiredoxinsProtein BindingProtein FoldingCysteineMolecular ChaperonesPeroxiredoxins

Identifiers

PMID30737390
PMCPMC6368585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.